Crizotinib is an oral, first-in-class, small-molecule inhibitor of anaplastic lymphoma kinase (ALK), ROS1, and MET tyrosine kinases, primarily used to treat ALK-positive or ROS1-positive non-small cell lung cancer (NSCLC).
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea